Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedSep 29, 2025
DataAggregated Company Financials
Companies17
- 7D-3.0%
- 3M-9.4%
- 1Y-34.0%
- YTD-5.9%
Over the last 7 days, the Biotech industry has dropped 3.0%, driven by Heidelberg Pharma declining 16%. The industry has fallen 34% in the last year. Earnings are forecast to grow by 69% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 29 Sep 2025 | €3.3b | €756.5m | -€208,557,561.58 | 4x | -15.9x | 4.4x |
| Wed, 27 Aug 2025 | €3.5b | €756.4m | -€228,397,670.86 | 3.5x | -15.5x | 4.7x |
| Fri, 25 Jul 2025 | €2.3b | €770.0m | -€186,390,736.24 | 4x | -12.6x | 3x |
| Sun, 22 Jun 2025 | €2.3b | €772.7m | -€178,999,093.00 | 4.1x | -12.6x | 2.9x |
| Tue, 20 May 2025 | €2.2b | €745.4m | -€197,457,717.00 | 3.2x | -11.2x | 3x |
| Thu, 17 Apr 2025 | €2.2b | €836.7m | -€141,762,276.00 | 24.1x | -15.4x | 2.6x |
| Sat, 15 Mar 2025 | €2.2b | €791.8m | €74.2m | 13.8x | 30.1x | 2.8x |
| Mon, 10 Feb 2025 | €2.7b | €791.8m | €74.2m | 14.6x | 36.3x | 3.4x |
| Wed, 08 Jan 2025 | €2.8b | €791.8m | €74.2m | 15.8x | 37.7x | 3.5x |
| Fri, 06 Dec 2024 | €2.6b | €791.8m | €74.2m | 14.1x | 35.2x | 3.3x |
| Sun, 03 Nov 2024 | €2.6b | €866.1m | €170.1m | 11.8x | 15.3x | 3x |
| Tue, 01 Oct 2024 | €2.8b | €867.2m | €174.8m | 12x | 16.1x | 3.2x |
| Thu, 29 Aug 2024 | €2.6b | €868.4m | €171.3m | 14.3x | 15x | 3x |
| Sat, 27 Jul 2024 | €2.7b | €885.2m | €194.8m | 12.1x | 13.7x | 3x |
| Mon, 24 Jun 2024 | €2.7b | €884.7m | €119.3m | 12.2x | 22.2x | 3x |
| Wed, 22 May 2024 | €2.5b | €884.7m | €188.1m | 9.7x | 13.4x | 2.9x |
| Fri, 19 Apr 2024 | €2.5b | €773.3m | €10.0m | 8.9x | 254.2x | 3.3x |
| Sun, 17 Mar 2024 | €5.0b | €985.8m | -€246,110,500.00 | 10.3x | -20.2x | 5x |
| Tue, 13 Feb 2024 | €2.7b | €746.1m | -€35,822,108.00 | 12.7x | -76.4x | 3.7x |
| Thu, 11 Jan 2024 | €2.8b | €769.9m | -€145,885,802.00 | 13.2x | -19.3x | 3.7x |
| Sat, 09 Dec 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.5x | -17.9x | 3.7x |
| Mon, 06 Nov 2023 | €3.9b | €1.1b | -€71,826,014.00 | 12.7x | -54.3x | 3.6x |
| Wed, 04 Oct 2023 | €3.8b | €971.6m | -€197,588,171.00 | 9.1x | -19.2x | 3.9x |
| Fri, 01 Sep 2023 | €4.0b | €954.6m | -€53,433,635.00 | 19.1x | -74.3x | 4.2x |
| Sun, 30 Jul 2023 | €4.1b | €955.5m | -€219,213,323.00 | 29.2x | -18.7x | 4.3x |
| Tue, 27 Jun 2023 | €4.0b | €967.4m | -€212,883,319.00 | 27.4x | -18.7x | 4.1x |
| Thu, 25 May 2023 | €4.1b | €967.4m | -€209,726,026.00 | 34.2x | -19.3x | 4.2x |
| Sat, 22 Apr 2023 | €3.6b | €927.5m | -€212,495,695.00 | 13.5x | -17.1x | 3.9x |
| Mon, 20 Mar 2023 | €3.3b | €891.3m | -€215,269,844.00 | 9.9x | -15.6x | 3.8x |
| Wed, 15 Feb 2023 | €3.0b | €612.2m | -€74,714,393.00 | 11x | -40.6x | 5x |
| Fri, 13 Jan 2023 | €3.1b | €611.9m | -€53,407,435.00 | 11.6x | -57.7x | 5x |
| Sun, 11 Dec 2022 | €3.1b | €611.9m | -€53,407,435.00 | 11.3x | -57.4x | 5x |
| Tue, 08 Nov 2022 | €2.6b | €624.9m | -€39,165,157.00 | 8.1x | -65.6x | 4.1x |
| Thu, 06 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.1x | -19.7x | 4.1x |
Price to Earnings Ratio
-19.7x
Current Industry PE
- Investors are relatively neutral on the German Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 6.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.40% | |
| Healthcare | -2.44% | |
| Biotech | -3.00% | |
| Biotech | -3.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2INV 2invest | €13.40 | 1.5% +€1.1m | 27.6% | PE2.8x | |
| LQ0 Dextech Medical | €0.78 | 4.7% +€647.0k | 108.6% | PS49.2x | |
| VSC 4SC | €0.84 | 4.0% +€349.0k | -84.7% | PS45.5x | |
| 8V8 Genetic Analysis | €0.055 | 8.9% +€310.9k | 13.2% | PS2x | |
| MDG1 Medigene | €0.069 | 13.0% +€119.1k | -96.6% | PS0.1x |